novel technologies to assess gut health claims for carbohydrates subtheme: immunobarrier paul de vos...

6
Novel Technologies to assess Gut Health Claims for Carbohydrates subtheme: Immunobarrier Paul de Vos (UMCG) [email protected]

Upload: arron-ball

Post on 12-Jan-2016

215 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Novel Technologies to assess Gut Health Claims for Carbohydrates subtheme: Immunobarrier Paul de Vos (UMCG) p.de.vos@med.umcg.nl

Novel Technologies to assess Gut Health Claims for Carbohydrates

subtheme: ImmunobarrierPaul de Vos (UMCG)[email protected]

Page 2: Novel Technologies to assess Gut Health Claims for Carbohydrates subtheme: Immunobarrier Paul de Vos (UMCG) p.de.vos@med.umcg.nl

Carbohydrates

Design a technology platform: Design a technology platform: to assess health benefits that meet EFSA requirement

Page 3: Novel Technologies to assess Gut Health Claims for Carbohydrates subtheme: Immunobarrier Paul de Vos (UMCG) p.de.vos@med.umcg.nl

ImmunemodulatoryFood components

Food componentsStimulating specific immunity/memory

Food enhanced stimulation ofepithelial barrier

Delivery and uptake of fragilevitamines, carbohydrates,fibers etc

Design a technology platform: Design a technology platform: to assess health benefits that meet EFSA requirement

Page 4: Novel Technologies to assess Gut Health Claims for Carbohydrates subtheme: Immunobarrier Paul de Vos (UMCG) p.de.vos@med.umcg.nl

1. HTP screening to identify immunemodulatingcarbohydrates and get insight in stage/mechanismof effect.

Design a technology platform: Design a technology platform: to assess health benefits that meet EFSA requirement

2. Testing in appropriate animal model(eg vaccination, allergy, Th1 and Th2 etc)

Successful compounds will enter subthemehuman studies (healthy/adults/infants)

Identification of specific effect:(i) Immune stimulation/suppressing/regulatory(ii) Beneficial for adults, infants, diseased or healthy subjects, male or female

Page 5: Novel Technologies to assess Gut Health Claims for Carbohydrates subtheme: Immunobarrier Paul de Vos (UMCG) p.de.vos@med.umcg.nl

1. HTP screening to identify immunemodulatingcarbohydrates and get insight in stage/mechanismof effect.

Design a technology platform: Design a technology platform: to assess health benefits that meet EFSA requirement

2. Testing in appropriate animal modelBased on results of 1. in depth analysis on mechanisms in experimental animal studies

Assays to measure effect on mucus production/function,Assays to measure effect on gut epithelium (permeability, defensins etc)Assays to measure effect on lymphocytes/dendriticsAssays to identify effects on pattern recognition receptors

Combined leads to insight how and where carbohydrates work

Vaccination, Pseudomonas, RSV, Rota, influenza, Listeria monoc., Trichinella Spiralis infection models, Allergy models (cow’s milk, henns egg, peanut allergy), DTH models, autoimmune diabetes models, asthma models, COPD models, cachexia models, inflammation models, arthritis (OA)/RA models

Page 6: Novel Technologies to assess Gut Health Claims for Carbohydrates subtheme: Immunobarrier Paul de Vos (UMCG) p.de.vos@med.umcg.nl

Design a technology platform: Design a technology platform: to assess health benefits that meet EFSA requirement

H. WichersH. SchmidtH. SavelkoulJ. DekkerJ. MesH. Schols...........

J. Garssen...........

P. de VosM.M. FaasH.J. VerkadeM. Priebe...........

(expertise: HTP systems, animals models)

Other contributing institutes/companies and participants welcome !